OSBR 3
ORMDL regulator 3 biosinteze sfingolipida je protein koji je kod ljudi kodiran genom ORMDL3.[5] Ovaj gen povezan je s astmom u djetinjstvu.[6] Transgeni miševi koji prekomerno eksprimiraju ljudski ORMDL3 povećali su nivo IgE. To je povezano sa povećanim brojem makrofaga, neutrofila, eozinofila , CD4 + T-ćelija antitumorske imunosti CD4 + i pojačanog Th2 nivoa citokina u plućnom tkivu.[7]
OSBR 3 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifikatori | |||||||||||||||||||||||||
Aliasi | ORMDL3 | ||||||||||||||||||||||||
Vanjski ID-jevi | OMIM: 610075 MGI: 1913862 HomoloGene: 57032 GeneCards: ORMDL3 | ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
Ortolozi | |||||||||||||||||||||||||
Vrste | Čovjek | Miš | |||||||||||||||||||||||
Entrez | |||||||||||||||||||||||||
Ensembl | |||||||||||||||||||||||||
UniProt | |||||||||||||||||||||||||
RefSeq (mRNK) | |||||||||||||||||||||||||
RefSeq (bjelančevina) | |||||||||||||||||||||||||
Lokacija (UCSC) | Chr 17: 39.92 – 39.93 Mb | Chr 11: 98.47 – 98.48 Mb | |||||||||||||||||||||||
PubMed pretraga | [3] | [4] | |||||||||||||||||||||||
Wikipodaci | |||||||||||||||||||||||||
|
Dužina polipeptidnog lanca je 153 aminokiselina, sa molekulskom težinom od 17.495.[8].
Aminokiselinska sekvenca
- Simboli
F: Fenilalanin
G: Glicin
H: Histidin
I: Izoleucin
K: Lizin
L: Leucin
M: Metionin
N: Asparagin
P: Prolin
Q: Glutamin
R: Arginin
S: Serin
T: Treonin
V: Valin
W: Triptofan
Y: Tirozin
10 | 20 | 30 | 40 | 50 | ||||
---|---|---|---|---|---|---|---|---|
MNVGTAHSEV | NPNTRVMNSR | GIWLSYVLAI | GLLHIVLLSI | PFVSVPVVWT | ||||
LTNLIHNMGM | YIFLHTVKGT | PFETPDQGKA | RLLTHWEQMD | YGVQFTASRK | ||||
FLTITPIVLY | FLTSFYTKYD | QIHFVLNTVS | LMSVLIPKLP | QLHGVRIFGI | ||||
NKY |
Lokalizacija
urediGen ORMDL3 miša i čovjeka kodira sekvencu od 153 aa. Porodica ORMDL sastoji se od tri člana (ORMDL1-3), koji su lokalizovani u membrani endoplazmatskog retikuluma (ER).[9] Ljudski ORMDL1, ORMDL2 i ORMDL3 lokalizirani su u hromosomimskim pozicijama 2q32, 12q13.2 a 17q21.[10]
Funkcija
urediORMDL3 ima ulogu u sintezi sfingolipida, kao negativnih regulatora.[9][11] Također ima ulogu u regulaciji nivoa Ca2+ u endoplazmatskom retikulumu. ER je vrlo važan za stvaranje, signalizaciju, funkcioniranje i skladištenje unutarćelijskog Ca2+. Postoje kanali koji kontroliraju izlaz Ca 2+ + iz ER u citoplazmu, a također pumpe (sarkoplazmatski retikulum Ca2+ATPaza (SERCA)) koje vraćaju Ca2+ natrag u ER.[12] Disregulacija Ca2+ ima ključnu ulogu u nekoliko patoloških stanja, poput disfunkcije SERCA, astme,[13] i Alzheimerove bolesti.[14]
Klinički značaj
urediMutacije u ORMDL3 povezane su sa upalnim bolestima, kao što su Crohnova bolest, tip 1 diabetes mellitus tip 1,[15] i reumatiodni artritis.[16]
Reference
uredi- ^ a b c GRCh38: Ensembl release 89: ENSG00000172057 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038150 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: ORMDL sphingolipid biosynthesis regulator 3".
- ^ Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, et al. (juli 2007). "Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma" (PDF). Nature. 448 (7152): 470–3. Bibcode:2007Natur.448..470M. doi:10.1038/nature06014. hdl:2027.42/62682. PMID 17611496. S2CID 4373589.
- ^ Miller M, Rosenthal P, Beppu A, Mueller JL, Hoffman HM, Tam AB, et al. (april 2014). "ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma". Journal of Immunology. 192 (8): 3475–87. doi:10.4049/jimmunol.1303047. PMC 3981544. PMID 24623133.
- ^ "UniProt, Q8N138". Pristupljeno September 12, 2017.
- ^ a b Davis D, Kannan M, Wattenberg B (decembar 2018). "Orm/ORMDL proteins: Gate guardians and master regulators". Advances in Biological Regulation. Sphingolipid Signaling in Chronic Disease. 70: 3–18. doi:10.1016/j.jbior.2018.08.002. PMC 6251742. PMID 30193828.
- ^ Hjelmqvist L, Tuson M, Marfany G, Herrero E, Balcells S, Gonzàlez-Duarte R (2002). "ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins". Genome Biology. 3 (6): RESEARCH0027. doi:10.1186/gb-2002-3-6-research0027. PMC 116724. PMID 12093374.
- ^ Breslow DK, Collins SR, Bodenmiller B, Aebersold R, Simons K, Shevchenko A, et al. (februar 2010). "Orm family proteins mediate sphingolipid homeostasis". Nature. 463 (7284): 1048–53. Bibcode:2010Natur.463.1048B. doi:10.1038/nature08787. PMC 2877384. PMID 20182505.
- ^ Berridge MJ, Lipp P, Bootman MD (oktobar 2000). "The versatility and universality of calcium signalling". Nature Reviews. Molecular Cell Biology. 1 (1): 11–21. doi:10.1038/35036035. PMID 11413485. S2CID 13150466.
- ^ Mahn K, Hirst SJ, Ying S, Holt MR, Lavender P, Ojo OO, et al. (juni 2009). "Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma". Proceedings of the National Academy of Sciences of the United States of America. 106 (26): 10775–80. Bibcode:2009PNAS..10610775M. doi:10.1073/pnas.0902295106. PMC 2699374. PMID 19541629.
- ^ Green KN, LaFerla FM (juli 2008). "Linking calcium to Abeta and Alzheimer's disease". Neuron. 59 (2): 190–4. doi:10.1016/j.neuron.2008.07.013. PMID 18667147. S2CID 17020942.
- ^ Verlaan DJ, Berlivet S, Hunninghake GM, Madore AM, Larivière M, Moussette S, et al. (septembar 2009). "Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease". American Journal of Human Genetics. 85 (3): 377–93. doi:10.1016/j.ajhg.2009.08.007. PMC 2771592. PMID 19732864.
- ^ Kurreeman FA, Stahl EA, Okada Y, Liao K, Diogo D, Raychaudhuri S, et al. (mart 2012). "Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12". American Journal of Human Genetics. 90 (3): 524–32. doi:10.1016/j.ajhg.2012.01.010. PMC 3309197. PMID 22365150.
Dopunska literatura
uredi- Hirota T, Harada M, Sakashita M, Doi S, Miyatake A, Fujita K, et al. (mart 2008). "Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population". The Journal of Allergy and Clinical Immunology. 121 (3): 769–70. doi:10.1016/j.jaci.2007.09.038. PMID 18155279.
- Galanter J, Choudhry S, Eng C, Nazario S, Rodríguez-Santana JR, Casal J, et al. (juni 2008). "ORMDL3 gene is associated with asthma in three ethnically diverse populations". American Journal of Respiratory and Critical Care Medicine. 177 (11): 1194–200. doi:10.1164/rccm.200711-1644OC. PMC 2408437. PMID 18310477.
- Tavendale R, Macgregor DF, Mukhopadhyay S, Palmer CN (april 2008). "A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications". The Journal of Allergy and Clinical Immunology. 121 (4): 860–3. doi:10.1016/j.jaci.2008.01.015. PMID 18395550.
- Sleiman PM, Annaiah K, Imielinski M, Bradfield JP, Kim CE, Frackelton EC, et al. (decembar 2008). "ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry". The Journal of Allergy and Clinical Immunology. 122 (6): 1225–7. doi:10.1016/j.jaci.2008.06.041. PMID 18760456.